SCHEMBL31630700

SCHEMBL31630700

[2H]C1([2H])C([2H])([2H])C(CO)(Nc2nc(Cl)nc3c2SCC3)C1([2H])[2H]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL373964 0.87 — —
SCHEMBL14734141 0.85 LATS1 (0.33) —
SCHEMBL30639334 0.85 LATS1 (0.33) —
SCHEMBL31622422 0.80 — —
SCHEMBL30678844 0.79 PDE4B (0.34) —
SCHEMBL29277041 0.79 PDE4B (0.34) —
SCHEMBL31670511 0.77 — —
SCHEMBL19624252 0.73 — —
SCHEMBL31630529 0.73 — —
SCHEMBL31622413 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025124557-A1 DEUTERATED HETEROCYCLIC COMPOUND ACTING AS PDE4B INHIBITOR AND USE THEREOF 武汉人福创新药物研发中心有限公司 2025-06-19 — — WO disclosed
Send feedback